DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 91 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q2 2022. The put-call ratio across all filers is 0.35 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,123,024 | +39.2% | 91,526 | +35.4% | 0.00% | – |
| Q2 2023 | $806,953 | +171.7% | 67,584 | +204.3% | 0.00% | – |
| Q1 2023 | $297,000 | +19061.3% | 22,211 | -69.2% | 0.00% | – |
| Q4 2022 | $1,550 | -99.9% | 72,006 | -6.9% | 0.00% | – |
| Q3 2022 | $1,549,000 | +425.1% | 77,314 | +368.1% | 0.00% | – |
| Q2 2022 | $295,000 | +41.8% | 16,515 | -21.2% | 0.00% | – |
| Q1 2022 | $208,000 | -76.2% | 20,951 | -59.7% | 0.00% | – |
| Q4 2021 | $875,000 | +775.0% | 51,960 | +1130.4% | 0.00% | – |
| Q3 2021 | $100,000 | +9900.0% | 4,223 | +7720.4% | 0.00% | – |
| Q2 2021 | $1,000 | – | 54 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 9,663,645 | $95,863,000 | 39.92% |
| Atlas Venture Life Science Advisors, LLC | 8,201,638 | $81,360,000 | 10.29% |
| RA Capital Management | 6,060,090 | $60,116,000 | 1.31% |
| Boxer Capital, LLC | 1,189,943 | $11,804,000 | 0.61% |
| Samsara BioCapital, LLC | 202,500 | $2,009,000 | 0.51% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,086,449 | $20,698,000 | 0.46% |
| BVF INC/IL | 809,282 | $8,028,000 | 0.32% |
| Summit Rock Advisors, LP | 33,125 | $329,000 | 0.20% |
| Perceptive Advisors | 556,047 | $5,516,000 | 0.11% |
| Nan Fung Group Holdings Ltd | 11,445 | $114,000 | 0.05% |